Page last updated: 2024-11-05

xylazine and Angiogenesis, Pathologic

xylazine has been researched along with Angiogenesis, Pathologic in 2 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Johnson, MZ1
Crowley, PD1
Foley, AG1
Xue, C1
Connolly, C1
Gallagher, HC1
Buggy, DJ1
Bertollo, CM1
Oliveira, AC1
Rocha, LT1
Costa, KA1
Nascimento, EB1
Coelho, MM1

Other Studies

2 other studies available for xylazine and Angiogenesis, Pathologic

ArticleYear
Effect of perioperative lidocaine on metastasis after sevoflurane or ketamine-xylazine anaesthesia for breast tumour resection in a murine model.
    British journal of anaesthesia, 2018, Volume: 121, Issue:1

    Topics: Adrenergic alpha-Agonists; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Local; A

2018
Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models.
    European journal of pharmacology, 2006, Oct-10, Volume: 547, Issue:1-3

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Behavior, Animal; Body Temperature; Carrageenan; Dose

2006